Most naturally occurring folate derivatives in foods are highly sensitive to temperature, oxygen, light, and their stability is affected by food processing conditions. Edible polysaccharides (hydrocolloids) were evaluated for folic acid encapsulation, both as single and mixed polymers as a way of increasing folic acid stability. Results obtained from the study demonstrate for the first time dietary incorporation of encapsulated folic acid using Cheddar cheese as the delivery vehicle mitigates against hyperhomocysteinemia and monocyte/macrophage adhesion in mice. / Doctor of Philosophy (PhD)

The staling of baked products remains a significant cause of economic loss due to the loss of enjoyment seen as crumb firming occurs. The aims of the current project have been to investigate the stability of amylases in bakery formulations. In addition, the impact of partial hydrolysis products of starch on staling is investigated. Specific assays were used to measure ƒÑ-amylase and ƒÒ-amylase, in the presence of the other potentially interfering activity. ƒÑ-Amylase activity levels appeared to gradually increase during the proofing stages and then to decline upon heating of the dough. However, the activity remaining in the final baked loaf was readily measurable indicating that not all of the enzyme had been inactivated. Free and total ƒÒ-amylase activities were also measured and most was found to be in the free form. ƒÒ-Amylase was unstable with only relatively low activities remaining in the final baked loaf. It appears that of the two amylolytic enzymes, ƒÑ-a mylase is sufficiently stable that it may exert some impact on the crumb characteristics in the freshly baked product and during subsequent storage. In order to assess the likelihood that amylolysis is of significance to crumb characteristics, HPLC was used to analyse aqueous extracts for sugars. Commercial flours were found to contain low levels of sugars with maltose being the predominant sugar present. A number of commercial breads were also analysed and the composition found to vary between the different samples. Typically maltose was present at higher levels than the other sugars. When experimental loaves were analysed, the patterns showed that other sugars declined during proofing whereas maltose remained at readily measurable levels. Upon baking and subsequent storage the amounts of maltose increased. These results are consistent with the findings that some amylolytic activity remains in the baked product. In the third phase of this study, a potential means of investigating the role of particular carb ohydrates in product textures and staling rates was examined. The approach of spray drying was used to prepare microencapsulated maltodextrin. The encapsulating agents used were based upon rice starch and guar galactomannan. When these microcapsules were incorporated into the breadmaking formulation and baked, it appeared that softer crumb characteristics were achieved. The data also indicates an effect of delay in the staling rates. In a preliminary evaluation of the potential of two X-ray scattering methods, it was found that both techniques appear useful. The differences seen for samples of bread crumb analysed at various stages of storage did not show large differences in the intensity patterns. Of the two approaches, small angle analysis (SAXS) appears to show greater potential for application in ongoing studies of staling. In conclusion, cereal grain ƒÑ-amylase may be more stable during breadmaking than previously thought. There appears to be an increase in the level of some low molecular weight sugars in the final, baked product. Microencapsulation may offer a useful technique for the study of the role of specific carbohydrates during baking and storage of breads.

Diabetes is a debilitating disease affecting millions of people worldwide. The transplantation of insulin-producing, pancreatic islet cells has been an extensively explored approach for the treatment of Type 1 Diabetes. However, the need for a multi-donor source, the strong host immune responses, and a life-long immunosuppressive therapy regimen limits the widespread applicability of islet transplantation. Encapsulation of islet cells within a semi-permeable biomaterial as a means to mask transplanted cells from the host has been shown to be a viable option for the protection of islets upon transplantation. Recent advancements, incorporating additional knowledge of biomaterials, have revitalized the field of islet encapsulation. This thesis work focused on both micro- and nano-scale encapsulation techniques. Initially, a novel, covalently linked alginate-poly(ethylene glycol) (PEG), termed XAlginate-PEG, microcapsule was evaluated, and was shown to exhibit superior stability over traditional ionically bound alginate microcapsules. The XAlginate-PEG capsules exhibited a 5-fold decrease in osmotic swelling than traditional alginate microcapsules, and remained completely intact upon chelation of ionic interactions. In addition, in vitro study of the novel polymer matrix showed high compatibility with mouse insulinoma cell lines, rat and human islets. Furthermore, no disruption in islet function was observed upon encapsulation. The second study of this thesis work focused on the nano-scale encapsulation of islets with a single layer PEG coating. A PEG polymer was grafted directly on the collagen matrix of the islet capsule to form a stable amide bond. PEGylation of the islet cells was shown to camouflage inflammatory agents, such as tissue factor (TF), present on the surface of the islet, while maintaining islet morphology and function. In summary, PEG dampened coagulation cascade activation, and concealed activated factor X (afX) generation under pro-inflammatory culture conditions. The present findings contribute to the field of cellular encapsulation, both in the fabrication of novel encapsulation techniques and the evaluation of nano-scale coatings. The future potential of this research includes the attenuation of immune responses to transplanted cells, elimination of continuous immunosuppression, and provide flexibility in cell source. Furthermore, the platforms evaluated in this thesis are generalized for all cell types, thereby permitting translation of techniques to alternative cellular therapies.

Degenerative disc disease (DDD) is a medical condition whereby the intervertebral discs (IVD) of the human spine degenerates and may cause pain which significantly affects the quality of one掇 life. Its prevalence has sparked off much research in deciphering its causes and developing new treatments. Recently, attempts to treat this degenerative problem have turned to seeking answers from regenerative medicine. One approach is to deliver mesenchymal stem cells (MSCs) with or without carriers to the nucleus pulposus (NP) in degenerative disc to restore both its structural and functional properties. However, the optimal conditions and signals for inducing MSCs differentiation toward NP-like phenotype have not been identified. This work aimed to develop injectable microspheres with matrix microenvironment mimicking that of native NP tissue for MSCs delivery. Firstly, it was aimed to establish a collagen microencapsulation based 3D culture system for maintenance of the phenotype of nucleus pulposus cells (NPCs) and remodeling of the collagen matrix to one that was similar to the native NP. Secondly, it was aimed to optimize a decellularization protocol for complete removal of the encapsulated NPCs with minimal loss of remodeled extracellular matrix. Thirdly, it was aimed to investigate whether this acellular matrix produced by NPCs was inductive for MSCs discogenic differentiation. Finally, it was aimed to evaluate the efficacy of the MSC-seeded acellular matrix microspheres in a pilot rabbit disc degeneration model. It demonstrated that NPCs maintained their phenotype, survived within the collagen microspheres and produced NP-like ECM such as glycosaminoglycan (GAG) and collagen type II. GAG production of NPCs was found to positively correlate with the dosage of TGF-? within a short period, initial collagen concentration and cell seeding density. An optimized decellularization protocol with 50mM SB-10, 0.6mM SB-16 and 0.14% Triton X-200 was established to completely remove the encapsulated NPCs with partial retention of the GAG-rich matrix. The decellularized microspheres were able to be repopulated with human MSCs (hMSCs) or rabbit MSCs (rMSCs). Within the NPC-derived acellular matrix, the repopulated hMSCs were able to partially exhibit NPC phenotype with upregulated expression of a few NPC markers and NP-like ECM according to histological, biochemical, immunohistological and real-time PCR results. In the pilot in vivo evaluation study, preliminary results showed that intra-discal injection of MSCs reseeded acellular NPC-matrix microspheres maintained a better water content than the control MSC-microspheres without the NPC-derived acellular matrix. This work reconstituted in vitro a NP-like 3D matrix and provided preliminary evidence on discogenic differentiation of MSCs in such a matrix environment. This work laid down the foundation to future development of stem cell-based therapies for DDD. Further studies should focus on deciphering the soluble and insoluble composition of such a NP-like matrix environment and understanding the molecular mechanism of the cell-matrix interactions involved. / published_or_final_version / Mechanical Engineering / Doctoral / Doctor of Philosophy

The maximum contaminant level (MCL) for arsenic in drinking water was reduced to 10 parts per billion in 2006 by the USEPA. As a result, approximately 10,000 tons of arsenic-bearing residuals (ABSRs) are estimated to be generated every year from water treatment processes. It has also been established that the standard Toxicity Characteristic Leaching Procedure (TCLP), underestimates arsenic leaching from ABSRs, particularly under mature, mixed solid waste landfill conditions. This makes it critical to investigate stabilization technologies that would ensure long-term stability of arsenic residuals after disposal. Arsenic is ubiquitously associated with iron oxides in natural environments as well as water treatment residuals. Hence, knowledge of iron oxide transformations under landfill conditions is critical to understanding the fate and mobility of the associated arsenic. In this work, the effect of high local Fe(II) concentrations on ferrihydrite transformation pathways was studied. Magnetite was the sole transformation product in the presence of high local Fe(II) concentrations. In the absence of high Fe(II) concentrations, goethite was the major transformation product along with minor quantities of magnetite. These results have implications for arsenic mobility from ABSRs since goethite and magnetite have different arsenic sorption capacities and mechanisms. Two technologies were investigated for the stabilization of ABSRs - Arsenic Crystallization Technology (ACT) and Microencapsulation. The strategy for ACT was to convert ABSRs into minerals with a high arsenic capacity and long-term stability under landfill conditions. Scorodite, arsenate hydroxyapatites, ferrous arsenate, arsenated schwertmannite, tooeleite and silica-amended tooeleite, were synthesized and evaluated for their potential to serve as arsenic sinks using TCLP and a simulated landfill leachate test. Ferrous arsenate type solids and arsenated schwertmannite showed most promise in terms of low arsenic leachability and favorable synthesis conditions. Microencapsulation involved coating arsenic-loaded ferrihydrite with a mineral having high stability under landfill conditions. Based on results from a previous study, vivianite was investigated as a potential encapsulant for ABSRs. A modified version of the TCLP was used to evaluate the effectiveness of microencapsulation. Although vivianite did not prove to be a promising encapsulant, our efforts offer useful insights for the development of a successful microencapsulation technology for arsenic stabilization.

Currently, therapeutic proteins and peptides are delivered subcutaneously, as they are readily denatured in the acidic, protease rich environment of the stomach or gastrointestinal track and low bioavailability results from poor intestinal absorption through the paracellular route. Encapsulation of therapeutic peptides and proteins into polymeric micro- and nano- particle systems has been proposed as a possible strategy to overcome limitations to oral protein administration. Furthermore, it was shown that nanoparticles having diameters less than 5µm are able to be taken up by the M cells of Peyer’s patches found in intestinal mucosa . However, the current methodologies to produce particles within desired range involves organic solvents and several steps. In this study, spray drying was investigated as a microencapsulation alternative, as it offers the potential for single step operation, producing dry particles, with the potential for extending the microparticle size into the nano-range. The particles were produced by spray drying of alginate/protein solutions. The effect of spray drying operational parameters on particle properties such as recovery, residual activity and particle size was studied. Particle recovery depended on the inlet temperature of the drying air, whereas the particle size was affected by the feed rate and the alginate concentration of the feed solution. Increase in alginate:protein ratio increased protein stability during the process and shelf live experiments. Presence of 0.2 g trehalose/g particle increased the residual activity up to 90%. The resulting spherical micro and nanoparticles had smooth surfaces. Stable glycol-chitosan-ca-alginate particles were produced with single step operation. The resulting particles had mean diameter around 3.5μm and released 35% of the initial protein content to the simulated stomach environment within 2 hours. The protein distribution within the particle was studied by confocal laser scanning microscope with florescent labeled protein. The image showed protein deposition toward the surface of the particles. Total drying time and Peclet number was calculated for the particles and found to be 8.5 ms and 240, which indicates that particle formation was governed mainly by convection, which resulted in a hollow central region and protein distribution toward the particle surface. This study shows that stable alginate particles containing proteins can be produced in a single step by spray drying, where the particles had a mean size lower than the critical diameter necessary to be orally absorbed by M cell’s of the Peyer’s patches in the gastrointestinal tract and thus can be considered as a promising technology for oral peptide and protein delivery. / Thesis (Master, Chemical Engineering) -- Queen's University, 2007-10-30 12:20:47.728

Thesis (Ph. D.)--State University of New York at Binghamton, Department of Mechanical Engineering, 2006. / Includes bibliographical references (leaves 121-136).

Thesis (M.Sc.) (Hons.) -- University of Western Sydney, Hawkesbury, 2000. / A thesis presented for the fulfilment of Master of Science (Honours), Centre for Advanced Food Research, School of Science, Food and Horticulture, University of Western Sydney, Hawkesbury, December 2000. Spine title : Survival of probiotic bacteria in dairy foods. Bibliography : leaves 228-244.

Thesis (Ph.D.)--University of Western Sydney, 2005. / A thesis submitted to the University of Western Sydney, College of Health and Science, Centre for Plant and Food Science, in fulfilment of the requirements for the degree of Doctor of Philosophy. Includes bibliographies.

Misturas aquosas de polissacarídeos e proteínas são normalmente instáveis e separam-se em fases devido às interações repulsivas ou atrativas existentes entre os polímeros. O efeito da temperatura, do pH e da concentração polimérica no comportamento de misturas de pectina/caseína foi estudado nesse trabalho. Um diagrama de fases construído em pH 7 revelou que a mistura é estável apenas em baixas concentrações. Concentrações mais elevadas levam à incompatibilidade termodinâmica, governada por forças puramente entrópicas, e ao aparecimento de duas fases: uma rica em caseína (inferior) e outra rica em pectina (superior). A decomposição espinodal pôde ser visualizada nos estágios iniciais da separação de fases e, nos estágios intermediários, observou-se a formação de emulsões água/água. Quando o pH dessas emulsões é reduzido para abaixo de 6, a pectina é atraída para a fase de caseína, resultando na formação de partículas de complexo pectina/caseína que não coalescem e são resistentes à adição de sal (NaCl 100 mM), apresentando um diâmetro médio aproximado de 4 m. As micropartículas de pectina/caseína produzidas por este método demonstraram ser capazes de encapsular com alta eficiência tanto substâncias hidrofóbicas quanto hidrofílicas, possibilitando sua aplicação na encapsulação de compostos variados para fins diversos. Neste trabalho, as micropartículas foram utilizadas para encapsular cristais de metronidazol e sua utilização na obtenção de filmes de aplicação intra-bolsa periodontal foi avaliada in vitro. As dispersões de pectina/caseína contendo as micropartículas carregadas foram submetidas à secagem para a obtenção dos filmes. Estes, reticulados ou não com cálcio, sustentaram a liberação in vitro do fármaco por pelo menos 7 dias in vitro. A reticulação foi importante para reduzir a desintegração dos filmes, contribuindo para aumentar o tempo de permanência deles no local de aplicação e para melhorar suas propriedades mecânicas, facilitando seu manuseio e inserção na bolsa periodontal. Com esses resultados, conclui-se que os filmes de micropartículas de complexo pectina/caseína contendo metronidazol desenvolvidos neste trabalho são excelentes candidatos a sistemas de liberação local para o tratamento da doença periodontal. / Aqueous mixtures of polysaccharides and proteins are usually unstable and phase-separate either because of repulsive or attractive interactions. The effect of temperature, pH, and biopolymer concentration on the phase behavior of pectin/casein mixtures was investigated. A phase diagram built at pH 7 revealed that the mixture is stable at low polymer concentrations. Higher concentrations lead to thermodynamic incompatibility, driven purely by entropic forces, and to the appearance of two phases: one enriched with casein (lower) and the other, with pectin (upper). Spinodal decomposition was visualized in the early stages of phase separation. In the intermediate stages, water-in-water emulsions were observed. When the pH of these emulsions was lowered below 6, pectin was attracted by casein-rich phase, resulting in the formation of particles (diameter ~ 4 m) of pectin/casein complex, which do not coalesce and are insensitive to salt addition (100 mM NaCl). Pectin/casein microparticles obtained by this method were able to encapsulate with high efficiency either hydrophobic or hydrophilic substances and, due to that, could be applied in the encapsulation of a great variety of compounds for different purposes. In this work, the pectin/casein microparticles were used to encapsulate metronidazole crystals and the preparation of intra-periodontal pocket films with them was evaluated. Therefore, dispersions of loaded pectin/casein microparticles were dried in an oven. Films cross-linked or not with calcium sustained the in vitro drug release at least for 7 days. The cross-linking with calcium was important to reduce film disintegration, accounting for its permanence in the applied region, and to improve the mechanical properties, which facilitates manipulation and insertion into the periodontal pocket. With these results we conclude that the films formed by microparticles of pectin/casein complex loaded with metronidazole are excellent candidates for local drug delivery systems for the treatment of periodontal disease.